Mouse TNFRSF9/4-1BB PicoKine ELISA Kit
To Order Contact us: [email protected]
4-1BB Receptor, TNFRSF9, human |
|||
| RC214-25R | Bio Basic | 5ug | EUR 104.38 |
Recombinant 4-1BB / TNFRSF9 Protein |
|||
| VAng-2776Lsx-1mg | Creative Biolabs | 1 mg | EUR 6044 |
|
Description: Recombinant 4-1BB / TNFRSF9 Protein was expressed in E. coli. (Uniprot ID: Q07011) |
|||
Recombinant 4-1BB / TNFRSF9 Protein |
|||
| VAng-2776Lsx-20g | Creative Biolabs | 20 µg | EUR 655 |
|
Description: Recombinant 4-1BB / TNFRSF9 Protein was expressed in E. coli. (Uniprot ID: Q07011) |
|||
4-1BB / TNFRSF9 Recombinant Protein |
|||
| 11-142 | ProSci | 0.1 mg | EUR 595.25 |
|
Description: 4-1BB is also known as CD137, tumor necrosis factor receptor superfamily member 9 (TNFRSF9), induced by lymphocyte activation (ILA), is a co-stimulatory molecule of the tumor necrosis factor (TNF) receptor superfamily. CD137 can be expressed by activated T cells, but to a larger extent on CD8 than on CD4 T cells. In addition, CD137 expression is found on dendritic cells, follicular dendritic cells, natural killer cells, granulocytes and cells of blood vessel walls at sites of inflammation. The best characterized activity of CD137 is its costimulatory activity for activated T cells. Crosslinking of CD137 enhances T cell proliferation, IL-2 secretion survival and cytolytic activity. Further, it can enhance immune activity to eliminate tumors in mice. CD137 can enhance activation-induced T cell apoptosis when triggered by engagement of the TCR/CD3 complex. In addition, 4-1BB/4-1BBL co-stimulatory pathway has been shown to augment secondary CTL responses to several viruses, and meanwhile augment anti-tumor immunity. 4-1BB thus is a promising candidate for immunotherapy of human cancer. CD137 has been shown to interact with TRAF2. |
|||
4-1BB / TNFRSF9 Recombinant Protein |
|||
| 11-149 | ProSci | 0.1 mg | EUR 595.25 |
|
Description: 4-1BB is also known as CD137, tumor necrosis factor receptor superfamily member 9 (TNFRSF9), induced by lymphocyte activation (ILA), is a co-stimulatory molecule of the tumor necrosis factor (TNF) receptor superfamily. CD137 can be expressed by activated T cells, but to a larger extent on CD8 than on CD4 T cells. In addition, CD137 expression is found on dendritic cells, follicular dendritic cells, natural killer cells, granulocytes and cells of blood vessel walls at sites of inflammation. The best characterized activity of CD137 is its costimulatory activity for activated T cells. Crosslinking of CD137 enhances T cell proliferation, IL-2 secretion survival and cytolytic activity. Further, it can enhance immune activity to eliminate tumors in mice. CD137 can enhance activation-induced T cell apoptosis when triggered by engagement of the TCR/CD3 complex. In addition, 4-1BB/4-1BBL co-stimulatory pathway has been shown to augment secondary CTL responses to several viruses, and meanwhile augment anti-tumor immunity. 4-1BB thus is a promising candidate for immunotherapy of human cancer. CD137 has been shown to interact with TRAF2. |
|||
4-1BB / TNFRSF9 Recombinant Protein |
|||
| 11-324 | ProSci | 0.1 mg | EUR 595.25 |
|
Description: 4-1BB is also known as CD137, tumor necrosis factor receptor superfamily member 9 (TNFRSF9), induced by lymphocyte activation (ILA), is a co-stimulatory molecule of the tumor necrosis factor (TNF) receptor superfamily. CD137 can be expressed by activated T cells, but to a larger extent on CD8 than on CD4 T cells. In addition, CD137 expression is found on dendritic cells, follicular dendritic cells, natural killer cells, granulocytes and cells of blood vessel walls at sites of inflammation. The best characterized activity of CD137 is its costimulatory activity for activated T cells. Crosslinking of CD137 enhances T cell proliferation, IL-2 secretion survival and cytolytic activity. Further, it can enhance immune activity to eliminate tumors in mice. CD137 can enhance activation-induced T cell apoptosis when triggered by engagement of the TCR/CD3 complex. In addition, 4-1BB/4-1BBL co-stimulatory pathway has been shown to augment secondary CTL responses to several viruses, and meanwhile augment anti-tumor immunity. 4-1BB thus is a promising candidate for immunotherapy of human cancer. CD137 has been shown to interact with TRAF2. |
|||
4-1BB / TNFRSF9 Recombinant Protein |
|||
| 11-497 | ProSci | 0.1 mg | EUR 542.75 |
|
Description: 4-1BB is also known as CD137, tumor necrosis factor receptor superfamily member 9 (TNFRSF9), induced by lymphocyte activation (ILA), is a co-stimulatory molecule of the tumor necrosis factor (TNF) receptor superfamily. CD137 can be expressed by activated T cells, but to a larger extent on CD8 than on CD4 T cells. In addition, CD137 expression is found on dendritic cells, follicular dendritic cells, natural killer cells, granulocytes and cells of blood vessel walls at sites of inflammation. The best characterized activity of CD137 is its costimulatory activity for activated T cells. Crosslinking of CD137 enhances T cell proliferation, IL-2 secretion survival and cytolytic activity. Further, it can enhance immune activity to eliminate tumors in mice. CD137 can enhance activation-induced T cell apoptosis when triggered by engagement of the TCR/CD3 complex. In addition, 4-1BB/4-1BBL co-stimulatory pathway has been shown to augment secondary CTL responses to several viruses, and meanwhile augment anti-tumor immunity. 4-1BB thus is a promising candidate for immunotherapy of human cancer. CD137 has been shown to interact with TRAF2. |
|||
ELISA kit for Human TNFRSF9/4-1BB |
|||
| EK5461 | SAB | 96 tests | EUR 553 |
|
Description: Enzyme-linked immunosorbent assay kit for quantification of Human TNFRSF9/4-1BB in samples from serum, plasma, tissue homogenates and other biological fluids. |
|||
Recombinant Mouse 4-1BB/TNFRSF9/CD137 (C-Fc) |
|||
| CI69-10ug | Novoprotein | 10ug | EUR 141 |
|
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
|||
Recombinant Mouse 4-1BB/TNFRSF9/CD137 (C-Fc) |
|||
| CI69-1mg | Novoprotein | 1mg | EUR 1674 |
|
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
|||
Recombinant Mouse 4-1BB/TNFRSF9/CD137 (C-Fc) |
|||
| CI69-500ug | Novoprotein | 500ug | EUR 1115 |
|
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
|||
Recombinant Mouse 4-1BB/TNFRSF9/CD137 (C-Fc) |
|||
| CI69-50ug | Novoprotein | 50ug | EUR 303 |
|
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
|||
Recombinant Human 4-1BB/TNFRSF9/CD137 Protein |
|||
| RP00466 | Abclonal | 10 μg | EUR 155 |
Recombinant 4-1BB / TNFRSF9 Protein (CHO cells) |
|||
| VAng-2782Lsx-200g | Creative Biolabs | 200 µg | EUR 2099 |
|
Description: Recombinant 4-1BB / TNFRSF9 Protein was expressed in CHO cells. (Uniprot ID: Q07011) |
|||
Recombinant 4-1BB / TNFRSF9 Protein (Baculovirus) [His] |
|||
| VAng-2786Lsx-250g | Creative Biolabs | 250 µg | EUR 2594 |
|
Description: Recombinant mouse 4-1BB / TNFRSF9 Protein was expressed in Baculovirus. (Uniprot ID: Q07011) |
|||
Recombinant 4-1BB / TNFRSF9 Protein (Baculovirus) [His] |
|||
| VAng-2786Lsx-50g | Creative Biolabs | 50 µg | EUR 903 |
|
Description: Recombinant mouse 4-1BB / TNFRSF9 Protein was expressed in Baculovirus. (Uniprot ID: Q07011) |
|||
Human CellExp? 4-1BB / TNFRSF9, Human recombinant |
|||
| 9227-10 | Biovision | EUR 267 | |
Human CellExp? 4-1BB / TNFRSF9, Human recombinant |
|||
| 9227-50 | Biovision | EUR 713 | |
TNFRSF9/4-1BB ELISA Kit| Mouse Tumor necrosis factor receptor su |
|||
| EF012924 | Lifescience Market | 96 Tests | EUR 689 |
Recombinant Mouse 4-1BB / TNFRSF9 Protein (aa 24-256) |
|||
| VAng-2778Lsx-100g | Creative Biolabs | 100 µg | EUR 6333 |
|
Description: Recombinant 4-1BB / TNFRSF9 Protein was expressed in cell free expression systems. (Uniprot ID: P20334) |
|||
Recombinant Mouse 4-1BB / TNFRSF9 Protein (aa 24-256) |
|||
| VAng-2778Lsx-50g | Creative Biolabs | 50 µg | EUR 3789 |
|
Description: Recombinant 4-1BB / TNFRSF9 Protein was expressed in cell free expression systems. (Uniprot ID: P20334) |
|||
Recombinant Mouse 4-1BB / TNFRSF9 Protein (aa 24-187) |
|||
| VAng-2781Lsx-100g | Creative Biolabs | 100 µg | EUR 930 |
|
Description: Recombinant mouse 4-1BB / TNFRSF9 Protein was expressed in E. coli. (Uniprot ID: P20334) |
|||
Recombinant Mouse 4-1BB / TNFRSF9 Protein (aa 24-187) |
|||
| VAng-2781Lsx-1mg | Creative Biolabs | 1 mg | EUR 3445 |
|
Description: Recombinant mouse 4-1BB / TNFRSF9 Protein was expressed in E. coli. (Uniprot ID: P20334) |
|||
Recombinant Mouse 4-1BB / TNFRSF9 Protein (aa 24-187) |
|||
| VAng-2781Lsx-500g | Creative Biolabs | 500 µg | EUR 2250 |
|
Description: Recombinant mouse 4-1BB / TNFRSF9 Protein was expressed in E. coli. (Uniprot ID: P20334) |
|||
Recombinant Human 4-1BB Receptor Protein |
|||
| PROTQ07011-4 | BosterBio | 20ug | EUR 317 |
|
Description: 4-1BB Receptor, a member of the TNF superfamily of receptors, is mainly expressed on the surface of a variety of T cells, but also found in B cells, monocytes, and various transformed cell lines. 4-1BB Receptor binds to 4-1BBL to provide a co-stimulatory signal for T lymphocytes. Signaling by 4-1BB Receptor has been implicated in the antigen-presentation process and generation of cytotoxic T cells. The human 4-1BB Receptor gene codes for a 255 amino acid type I transmembrane protein containing a 17 amino acid N-terminal signal sequence, a 169 amino acid extracellular domain, a 27 amino acid transmembrane domain and a 42 amino acid cytoplasmic domain. Recombinant human soluble 4-1BB Receptor is a 167 amino acid polypeptide (17.7 kDa), which contains the cysteine rich TNFR-like extracellular domain of 4-1BB Receptor. |
|||
Recombinant 4-1BB / TNFRSF9 Protein (Sf9 Baculovirus Cells) |
|||
| VAng-2785Lsx-10g | Creative Biolabs | 10 µg | EUR 614 |
|
Description: Recombinant mouse 4-1BB / TNFRSF9 Protein was expressed in Sf9 Baculovirus Cells. (Uniprot ID: Q07011) |
|||
Recombinant 4-1BB / TNFRSF9 Protein (Sf9 Baculovirus Cells) |
|||
| VAng-2785Lsx-1mg | Creative Biolabs | 1 mg | EUR 13838 |
|
Description: Recombinant mouse 4-1BB / TNFRSF9 Protein was expressed in Sf9 Baculovirus Cells. (Uniprot ID: Q07011) |
|||
Recombinant Human 4-1BB/TNFRSF9/CD137 (C-6His) |
|||
| CP05-10ug | Novoprotein | 10ug | EUR 80 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Human 4-1BB/TNFRSF9/CD137 (C-6His) |
|||
| CP05-1mg | Novoprotein | 1mg | EUR 1014 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Human 4-1BB/TNFRSF9/CD137 (C-6His) |
|||
| CP05-500ug | Novoprotein | 500ug | EUR 659 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Human 4-1BB/TNFRSF9/CD137 (C-6His) |
|||
| CP05-50ug | Novoprotein | 50ug | EUR 141 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Human 4-1BB/TNFRSF9/CD137 (C-Fc) |
|||
| CP10-10ug | Novoprotein | 10ug | EUR 80 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Human 4-1BB/TNFRSF9/CD137 (C-Fc) |
|||
| CP10-1mg | Novoprotein | 1mg | EUR 1014 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Human 4-1BB/TNFRSF9/CD137 (C-Fc) |
|||
| CP10-500ug | Novoprotein | 500ug | EUR 659 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Human 4-1BB/TNFRSF9/CD137 (C-Fc) |
|||
| CP10-50ug | Novoprotein | 50ug | EUR 141 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Human 4-1BB/TNFRSF9/CD137 (C-mFC) |
|||
| CW21-10ug | Novoprotein | 10ug | EUR 146 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Human 4-1BB/TNFRSF9/CD137 (C-mFC) |
|||
| CW21-1mg | Novoprotein | 1mg | EUR 2283 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Human 4-1BB/TNFRSF9/CD137 (C-mFC) |
|||
| CW21-500ug | Novoprotein | 500ug | EUR 1613 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Human 4-1BB/TNFRSF9/CD137 (C-mFC) |
|||
| CW21-50ug | Novoprotein | 50ug | EUR 303 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Cynomolgus 4-1BB/TNFRSF9/CD137 (C-6His) |
|||
| CB18-10ug | Novoprotein | 10ug | EUR 126 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
|||
Recombinant Cynomolgus 4-1BB/TNFRSF9/CD137 (C-6His) |
|||
| CB18-1mg | Novoprotein | 1mg | EUR 1268 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
|||
Recombinant Cynomolgus 4-1BB/TNFRSF9/CD137 (C-6His) |
|||
| CB18-500ug | Novoprotein | 500ug | EUR 902 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
|||
Recombinant Cynomolgus 4-1BB/TNFRSF9/CD137 (C-6His) |
|||
| CB18-50ug | Novoprotein | 50ug | EUR 227 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
|||
Recombinant Cynomolgus 4-1BB/TNFRSF9/CD137 (C-Fc) |
|||
| CB19-10ug | Novoprotein | 10ug | EUR 126 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
|||
Recombinant Cynomolgus 4-1BB/TNFRSF9/CD137 (C-Fc) |
|||
| CB19-1mg | Novoprotein | 1mg | EUR 1268 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
|||
Recombinant Cynomolgus 4-1BB/TNFRSF9/CD137 (C-Fc) |
|||
| CB19-500ug | Novoprotein | 500ug | EUR 902 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
|||
Recombinant Cynomolgus 4-1BB/TNFRSF9/CD137 (C-Fc) |
|||
| CB19-50ug | Novoprotein | 50ug | EUR 227 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
|||
Mouse TNFRSF9/4-1BB EZ-Set™ ELISA Kit (DIY Antibody Pairs) |
|||
| EZ1143 | BosterBio | 5 plates/kit | EUR 309 |
|
Description: For the development of sandwich ELISA kit to measure mouse TNFRSF9/4-1BB in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA). |
|||
Recombinant Mouse 4-1BB / TNFRSF9 Protein (aa 24-187) [Fc] |
|||
| VAng-2784Lsx-50g | Creative Biolabs | 50 µg | EUR 1026 |
|
Description: Recombinant mouse 4-1BB / TNFRSF9 Protein was expressed in HEK 293 cells. (Uniprot ID: P20334) |
|||
Mouse TNFRSF9/4-1BB(Tumor necrosis factor receptor superfamily member 9) ELISA Kit |
|||
| EM0193 | FN Test | 96T | EUR 567.6 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Mus ;Sensitivity: 4.688pg/ml |
|||
Recombinant 4-1BB / TNFRSF9 Protein (aa 1-185) [Fc] |
|||
| VAng-2777Lsx-50g | Creative Biolabs | 50 µg | EUR 1618 |
|
Description: Recombinant 4-1BB / TNFRSF9 Protein was expressed in E. coli. (Uniprot ID: Q07011) |
|||
Recombinant 4-1BB / TNFRSF9 Protein (aa 40-153) [His] |
|||
| VAng-2783Lsx-1mg | Creative Biolabs | 1 mg | EUR 3940 |
|
Description: Recombinant 4-1BB / TNFRSF9 Protein, His tag, was expressed in E. coli. (Uniprot ID: Q07011) |
|||
Recombinant 4-1BB / TNFRSF9 Protein (aa 40-153) [His] |
|||
| VAng-2783Lsx-200g | Creative Biolabs | 200 µg | EUR 1411 |
|
Description: Recombinant 4-1BB / TNFRSF9 Protein, His tag, was expressed in E. coli. (Uniprot ID: Q07011) |
|||
Recombinant 4-1BB / TNFRSF9 Protein (aa 40-153) [His] |
|||
| VAng-2783Lsx-500g | Creative Biolabs | 500 µg | EUR 2675 |
|
Description: Recombinant 4-1BB / TNFRSF9 Protein, His tag, was expressed in E. coli. (Uniprot ID: Q07011) |
|||
Recombinant 4-1BB / TNFRSF9 Protein (Leu 24-Gln 186) |
|||
| VAng-0681Lsx-1mg | Creative Biolabs | 1 mg | EUR 6649 |
|
Description: Human 4-1BB low endotoxin was expressed in HEK 293 cells, with a molecular weight of 28-35 kDa. (Uniprot ID: Q07011-1) |
|||
Recombinant Human 4-1BB/TNFRSF9/CD137 (C-Fc-6His) |
|||
| CJ38-10ug | Novoprotein | 10ug | EUR 100 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS pH7.4. |
|||
Recombinant Human 4-1BB/TNFRSF9/CD137 (C-Fc-6His) |
|||
| CJ38-1mg | Novoprotein | 1mg | EUR 1115 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS pH7.4. |
|||
Recombinant Human 4-1BB/TNFRSF9/CD137 (C-Fc-6His) |
|||
| CJ38-500ug | Novoprotein | 500ug | EUR 709 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS pH7.4. |
|||